Table 2 Patient characteristics
|  | n = 196 (%); median | range |
|---|---|---|
Sex | ||
 female | 73 (37.1) |  |
 male | 123 (62.9) |  |
Medically inoperable | 182 (92.8) | Â |
Medically operable | 14 (7.2) | Â |
Localization | ||
 -central | 83 (42.3) |  |
 -peripheral | 113 (57.7) |  |
Side | ||
 -left | 86 (43.9) |  |
 -right | 110 (56.1) |  |
Grading (G) | ||
 G1 | 7 (3.6) |  |
 G2 | 74 (37.8) |  |
 G3 | 42 (21.4) |  |
Stage according to UICC (7th edition) | Â | |
 -I | 113 (57.7) |  |
 -II | 68 (34.6) |  |
 -IIIa | 15 (7.7) |  |
Histology | ||
 -Adenocarcinoma | 49 (39.9) |  |
 -Squamous cell carcinoma | 71 (57.7) |  |
 -Large cell carcinoma | 3 (2.4) |  |
 -No biopsy due to comorbidities | 73 (37.2) |  |
Age | 67 | 29–86 |
 0–50 | 6 (3.1) |  |
 50–65 | 63 (32.1) |  |
 66–80 | 101 (51.5) |  |
 > 80 | 26 (13.3) |  |
aCCI | 7 | 3–16 |
 0–3 | 4 (2.0) |  |
 4–6 | 63 (32.1) |  |
 7–9 | 62 (31.6) |  |
 10–12 | 44 (22.4) |  |
 > 12 | 23 (11.9) |  |
Hypertension | 119 (60.7) | Â |
Diabetes with or without end-organ damage | 52 (26.6) | Â |
Moderate/severe renal damage | 63 (32.1) | Â |
COPD | 167 (85.2) | Â |
 -Gold 1 + 2 | 51 (26.0) |  |
 -Gold 3 | 61 (31.1) |  |
 -Gold 4 | 55 (28.1) |  |
Peripheral vascular disease | 49 (25) | Â |
Myocardial infarction | 31 (15.8) | Â |
Congestive heart failure | 71 (36.2) | Â |
Cerebral vascular disease | 13 (6.6) | Â |
Mild liver disease | 9 (4.5) | Â |
Isocenter Dose | ||
 -peripheral tumor | 18.75 | 18–20 |
 -central tumor | 7.5 | 7–9 |
Packyears | 40 | 0–120 |